The latest biotech news

News and Trends 14 Dec 2022

OncoHost to launch PROphet for non-small cell lung cancer in the U.S. in 2023

Ofer Sharon is the CEO of OncoHost, a biotech company in the precision oncology space. A physician by training, Sharon has leveraged his experience in pharma drug development and entrepreneurship to lead OncoHost through the development of PROphet, the company’s host response profiling platform, which will launch in the U.S. for non-small cell lung cancer […]

December 14, 2022 - 7 minutesmins - By Jim Cornall

News and Trends 14 Dec 2022

Startup USSF bringing oral COVID vaccine to market

From a small biotech start-up firm in Allentown, Pennsylvania, two scientists are leading their team to bring an oral COVID-19 vaccine to market – one that will be easier to use, longer lasting and with fewer side effects. Kyle Flanigan and Garry Morefield co-founded US Specialty Formulations LLC (USSF) through discussions while watching their daughters […]

December 14, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 14 Dec 2022

How biotech startups can innovate through embracing applied research

By Kathleen Lee, director of the Arizona WearTech Applied Research Center Innovation is about breaking new ground and forging new pathways to confront societal issues and solve problems. Many startup companies, especially in the biotech industries, are working towards finding solutions to some of these most complex problems. All solutions start as mere ideas, and […]

December 14, 2022 - 5 minutesmins - By External Contributor

News and Trends 14 Dec 2022

Navigating running a startup as a Gen Z female founder

By: Alina Su, CEO and founder of NovaXS Biotech Corp The next generation of biotech founders are facing new challenges. Despite the access to a world of opportunity on the internet, pursuing your dreams as a Generation Z female biotech founder is not easy. Gen Z has the unpopular stereotype that they are lazy and […]

December 14, 2022 - 7 minutesmins - By External Contributor

News and Trends 14 Dec 2022

The crucial importance of project management for healthcare startups

By Clémentine Duflot, consultant at HC NEXT In an effervescent healthcare innovation field, where risk-assessment and time-to-market are key to break through and survive, speeding and derisking drug and medical device developments to ensure each innovation becomes a product to benefit patients is essential. A drug or medical device development project requires a high level […]

December 14, 2022 - 3 minutesmins - By External Contributor

News and Trends 13 Dec 2022

Watch: Interview with Medicon Village CEO Petter Hartman

Medicon Village, in Lund, southern Sweden, is part of a cluster of life science research and development, together with actors such as the European Spallation Source (ESS), the BioMedical Centre (BMC) at Lund University and the Max IV Laboratory. Medicon Village is divided into two companies – Medicon Village Fastighets AB and Medicon Village Innovation […]

December 13, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 13 Dec 2022

Ascletis announces positive COVID-19 trial results

Ascletis Pharma Inc. has announced positive topline results from its phase I multiple ascending dose (MAD) study in healthy subjects for oral RNA-dependent RNA polymerase (RdRp) inhibitor ASC10 for COVID-19 treatment. Ascletis’ ASC10 is an innovative orally available double prodrug, which has a new and differentiated chemical structure from the single prodrug molnupiravir. After oral […]

December 13, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 13 Dec 2022

Therabest and Glycotope to assess breast cancer combination treatment

Therabest USA. Inc, Therabest Korea and Glycotope GmbH have signed an agreement to assess the clinical development of Therabest’s EiNK (enhanced iPSC-derived NK) cell therapy, TB-100, in combination with Glycotope’s immuno-cytokine, GT-00AxIL15 in triple-negative breast cancer (TNBC) patients. NK (natural killer) cell therapies from various cell sources have demonstrated exciting results in early clinical trials […]

December 13, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 13 Dec 2022

Blood clotting research holds hope for sepsis

Researchers from the University of Birmingham in the U.K., who identified a novel mechanism for platelet activation in pathogenic blood clotting (thrombosis), are now turning their attention to sepsis. Identified by associate professor Julie Rayes and Martina Colicchia from the Birmingham Platelet Group, and described in a recent paper in Blood, this previously unknown axis […]

December 13, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 13 Dec 2022

Poolbeg influenza trial successfully completed

Poolbeg Pharma has received initial results having completed its lipopolysaccharide (LPS) human challenge clinical trial for POLB 001, a viral strain agnostic, small molecule immunomodulator being developed to address the unmet medical need for severe influenza. The study showed no further clinical activity is required to complete the objectives of the trial, bringing the recruitment […]

December 13, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 12 Dec 2022

Japanese research offers hope for Fukuyama muscular dystrophy patients

Fukuyama congenital muscular dystrophy (FCMD) is the second most common form of childhood muscular dystrophy in Japan. The disease manifests itself in the form of a severe neuromuscular disorder. One form of FCMD is caused by a genetic abnormality in the fukutin (FKTN) gene. The genetic anomaly blocks the chemical glycosylation of a biologically important […]

December 12, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 12 Dec 2022

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

OSE Immunotherapeutics SA has presented the latest preclinical data on the use of its anti-IL-7 receptor (IL-7R) antagonist OSE-127 for the treatment of B- and T-Cell acute lymphoblastic leukemia (B- and T-ALL). The information was provided at the American Society of Hematology (ASH) annual meeting in New Orleans, Louisiana. The preclinical data on OSE-127 presented […]

December 12, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

OncoHost to launch PROphet for non-small cell lung cancer in the U.S. in 2023

Startup USSF bringing oral COVID vaccine to market

How biotech startups can innovate through embracing applied research

Navigating running a startup as a Gen Z female founder

The crucial importance of project management for healthcare startups

Watch: Interview with Medicon Village CEO Petter Hartman

Ascletis announces positive COVID-19 trial results

Therabest and Glycotope to assess breast cancer combination treatment

Blood clotting research holds hope for sepsis

Poolbeg influenza trial successfully completed

Japanese research offers hope for Fukuyama muscular dystrophy patients

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!